Berenberg lowered the price target for the Healthcare Trust of America Inc. (NYSE:HTA) stock from ‘a Hold’ to ‘a Buy’. The rating was released on May 10, 2023, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $34. The stock was downgraded by Berenberg, who disclosed in a research note on November 24, 2021, from Buy to Hold and set the price objective to $37. In their research brief published September 30, 2021, Truist analysts downgraded the Healthcare Trust of America Inc.
brand B2C interfaces